Gustavo Monnerat: The Rejection Letter That Became a Nobel Prize
Gustavo Monnerat, Deputy Editor at The Lancet, shared a a post on LinkedIn:
“The Rejection Letter That Became a Nobel Prize, and What It Teaches Us
You’ve probably seen this letter before.
In 1992, Nature rejected Peter Ratcliffe’s paper
27 years later, he won the Nobel Prize for the same discovery.
This story if often used as a reminder to never lose faith.
And yes, perseverance matters a lot.
But there’s another lesson here:
Even the best ideas can be missed if they aren’t clearly written, contextualized, and supported by data that communicates their novelty and significance.
Editors and reviewers don’t reject ideas, they reject what they can’t fully see or understand.
And in a world where scientific output grows exponentially, clarity has become a key part of scientific impact.
5 Ways to Help Editors and Reviewers See the Value of Your Work
- Novelty & Significance
Make the advance explicit: what’s new, why it matters, and how it moves the field forward. - Rigor & Transparency
Explain your methods so readers can trust and reproduce them. Clarity equals credibility. - Results & Data Storytelling
Let figures speak. Highlight the key contrast or effect in seconds, reviewers scan, not dig. - Interpretation & Implications
Go beyond results. Explain why the finding changes understanding or practice. - Integration & Next Steps
Situate your work in the broader scientific conversation, and show where it leads next.”

Stay updated with Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters